TWiV 727: COVID-19 clinical update #52 with Dr. Daniel Griffin
Mar 06, 2021•35 min•Ep. 727
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #52, Daniel Griffin reviews differences in attack rates between children and adults, J&J vaccine phase III data, G6PD deficiency and vaccines, NIH halts convalescent plasma trial, dexamethasone in hospitalized patients, data on tocilizumab, and long COVID in children.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- SARS-CoV-2 attack rates in children and adults (Clin Inf Dis)
- Documents for J&J COVID-19 vaccine review (FDA)
- Convalescent plasma and clinical outcomes (JAMA)
- NIH halts convalescent plasma trial (NIH)
- Dexamethasone in hospitalized COVID-19 patients (NEJM)
- Tocilizumab in hospitalized COVID-19 patients (NEJM)
- Update on long COVID prevalence (UK ONS)
- Letters read on TWiV 727
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android